BackHealthcare Services Acquisition - Warrants (18/11/2025) Overview
Healthcare Services Acquisition Corp - Warrants (18/11/2025)

Healthcare Services Acquisition - Warrants (18/11/2025) Return on Equity

Valuation check: HCARW's ROE is -109.56%, below the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

-109.56%

Return on Equity

-109.56%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Healthcare Services Acquisition - Warrants (18/11/2025) (HCARW) FAQ

Healthcare Services Acquisition - Warrants (18/11/2025) (HCARW) currently reports a ROE of -109.56%. That is below the sector sector average of -5.87%. Use the charts on this page to explore Healthcare Services Acquisition - Warrants (18/11/2025)'s ROE history and peer comparisons.

Healthcare Services Acquisition - Warrants (18/11/2025)'s ROE of -109.56% is lower than the its sector sector average of -5.87%. That is roughly 1767.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Healthcare Services Acquisition - Warrants (18/11/2025)'s current -109.56% should be judged against industry norms (sector average: -5.87%) and against HCARW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -109.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.87%. From there, open related valuation or income-statement pages for Healthcare Services Acquisition - Warrants (18/11/2025), and consider following HCARW for alerts when major investors trade the stock.